Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Clinical significance of long non-coding RNA HOTTIP in early-stage non-small-cell lung cancer.

Navarro A, Moises J, Santasusagna S, Marrades RM, Viñolas N, Castellano JJ, Canals J, Muñoz C, Ramírez J, Molins L, Monzo M.

BMC Pulm Med. 2019 Feb 28;19(1):55. doi: 10.1186/s12890-019-0816-8.

2.

Long non-coding RNA HOTTIP is correlated with progression and prognosis in tongue squamous cell carcinoma.

Zhang H, Zhao L, Wang YX, Xi M, Liu SL, Luo LL.

Tumour Biol. 2015 Nov;36(11):8805-9. doi: 10.1007/s13277-015-3645-2. Epub 2015 Jun 10.

PMID:
26058875
3.

Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.

Li B, Cui Y, Diehn M, Li R.

JAMA Oncol. 2017 Nov 1;3(11):1529-1537. doi: 10.1001/jamaoncol.2017.1609.

4.

A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer.

Zhou M, Guo M, He D, Wang X, Cui Y, Yang H, Hao D, Sun J.

J Transl Med. 2015 Jul 17;13:231. doi: 10.1186/s12967-015-0556-3.

5.

HOTTIP Functions as a Key Candidate Biomarker in Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatic Analysis.

Yin X, Yang W, Xie J, Wei Z, Tang C, Song C, Wang Y, Cai Y, Xu W, Han W.

Biomed Res Int. 2019 Mar 26;2019:5450617. doi: 10.1155/2019/5450617. eCollection 2019.

6.

Analysis of the long non-coding RNA LINC01614 in non-small cell lung cancer.

Sun Y, Ling C.

Medicine (Baltimore). 2019 Jul;98(30):e16437. doi: 10.1097/MD.0000000000016437.

7.

Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer.

Xie Y, Zhang Y, Du L, Jiang X, Yan S, Duan W, Li J, Zhan Y, Wang L, Zhang S, Li S, Wang L, Xu S, Wang C.

Mol Oncol. 2018 May;12(5):648-658. doi: 10.1002/1878-0261.12188. Epub 2018 Mar 25.

8.

Association of long non-coding RNA HOTTIP with progression and prognosis in colorectal cancer.

Ren YK, Xiao Y, Wan XB, Zhao YZ, Li J, Li Y, Han GS, Chen XB, Zou QY, Wang GC, Lu CM, Xu YC, Wang YC.

Int J Clin Exp Pathol. 2015 Sep 1;8(9):11458-63. eCollection 2015.

9.
10.

Long noncoding RNA VPS9D1-AS1 overexpression predicts a poor prognosis in non-small cell lung cancer.

Tan J, Yang L.

Biomed Pharmacother. 2018 Oct;106:1600-1606. doi: 10.1016/j.biopha.2018.07.113. Epub 2018 Jul 29.

PMID:
30119235
11.

Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.

Gu JX, Zhang X, Miao RC, Xiang XH, Fu YN, Zhang JY, Liu C, Qu K.

World J Gastroenterol. 2019 Jan 14;25(2):220-232. doi: 10.3748/wjg.v25.i2.220.

12.

NKX2-1 expression as a prognostic marker in early-stage non-small-cell lung cancer.

Moisés J, Navarro A, Santasusagna S, Viñolas N, Molins L, Ramirez J, Osorio J, Saco A, Castellano JJ, Muñoz C, Morales S, Monzó M, Marrades RM.

BMC Pulm Med. 2017 Dec 13;17(1):197. doi: 10.1186/s12890-017-0542-z.

13.

A genetic variant in long non-coding RNA MALAT1 associated with survival outcome among patients with advanced lung adenocarcinoma: a survival cohort analysis.

Wang JZ, Xiang JJ, Wu LG, Bai YS, Chen ZW, Yin XQ, Wang Q, Guo WH, Peng Y, Guo H, Xu P.

BMC Cancer. 2017 Mar 3;17(1):167. doi: 10.1186/s12885-017-3151-6.

14.

Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.

Tian L, Shan W, Zhang Y, Lv X, Li X, Wei C.

Pathol Oncol Res. 2016 Jan;22(1):161-7. doi: 10.1007/s12253-015-9979-7. Epub 2015 Oct 9. Erratum in: Pathol Oncol Res. 2016 Apr;22(2):439. Zhnag, Yufei [corrected to Zhang, Yufei].

PMID:
26453197
15.

Long non-coding RNA CARLo-5 is a negative prognostic factor and exhibits tumor pro-oncogenic activity in non-small cell lung cancer.

Luo J, Tang L, Zhang J, Ni J, Zhang HP, Zhang L, Xu JF, Zheng D.

Tumour Biol. 2014 Nov;35(11):11541-9. doi: 10.1007/s13277-014-2442-7. Epub 2014 Aug 17.

PMID:
25129441
16.

The up-regulation of long non-coding RNA AFAP1-AS1 is associated with the poor prognosis of NSCLC patients.

Deng J, Liang Y, Liu C, He S, Wang S.

Biomed Pharmacother. 2015 Oct;75:8-11. doi: 10.1016/j.biopha.2015.07.003. Epub 2015 Sep 2.

PMID:
26463625
17.

The prognostic value of long noncoding RNA HOTTIP on clinical outcomes in breast cancer.

Yang Y, Qian J, Xiang Y, Chen Y, Qu J.

Oncotarget. 2017 Jan 24;8(4):6833-6844. doi: 10.18632/oncotarget.14304. Review.

18.

Increased Expression of Long Non-Coding RNA BCAR4 Is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer.

Gong J, Zhang H, He L, Wang L, Wang J.

Tohoku J Exp Med. 2017 Jan;241(1):29-34. doi: 10.1620/tjem.241.29.

19.

Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma.

Zheng S, Zheng D, Dong C, Jiang J, Xie J, Sun Y, Chen H.

J Cancer Res Clin Oncol. 2017 Sep;143(9):1649-1657. doi: 10.1007/s00432-017-2411-9. Epub 2017 Apr 13.

PMID:
28409273
20.

The long noncoding RNA HOXA transcript at the distal tip promotes colorectal cancer growth partially via silencing of p21 expression.

Lian Y, Ding J, Zhang Z, Shi Y, Zhu Y, Li J, Peng P, Wang J, Fan Y, De W, Wang K.

Tumour Biol. 2016 Jun;37(6):7431-40. doi: 10.1007/s13277-015-4617-2. Epub 2015 Dec 17.

PMID:
26678886

Supplemental Content

Support Center